IL134163A0 - Chromium/biotin treatment of type ii diabetes - Google Patents

Chromium/biotin treatment of type ii diabetes

Info

Publication number
IL134163A0
IL134163A0 IL13416398A IL13416398A IL134163A0 IL 134163 A0 IL134163 A0 IL 134163A0 IL 13416398 A IL13416398 A IL 13416398A IL 13416398 A IL13416398 A IL 13416398A IL 134163 A0 IL134163 A0 IL 134163A0
Authority
IL
Israel
Prior art keywords
chromium
diabetes
biotin
type
biotin treatment
Prior art date
Application number
IL13416398A
Other languages
English (en)
Original Assignee
Nutrition 21
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26808096&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL134163(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/908,819 external-priority patent/US5789401A/en
Application filed by Nutrition 21 filed Critical Nutrition 21
Publication of IL134163A0 publication Critical patent/IL134163A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL13416398A 1997-08-08 1998-07-31 Chromium/biotin treatment of type ii diabetes IL134163A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/908,819 US5789401A (en) 1997-08-08 1997-08-08 High-dose chromium/biotin treatment of type II diabetes
US09/110,511 US5929066A (en) 1997-08-08 1998-07-06 Chromium/biotin treatment of Type II diabetes
PCT/US1998/016103 WO1999007387A1 (en) 1997-08-08 1998-07-31 Chromium/biotin treatment of type ii diabetes

Publications (1)

Publication Number Publication Date
IL134163A0 true IL134163A0 (en) 2001-04-30

Family

ID=26808096

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13416398A IL134163A0 (en) 1997-08-08 1998-07-31 Chromium/biotin treatment of type ii diabetes

Country Status (14)

Country Link
US (1) USRE39480E1 (cs)
EP (1) EP1001793B1 (cs)
JP (1) JP2001513506A (cs)
CN (1) CN1273531A (cs)
AT (1) ATE304364T1 (cs)
AU (1) AU751431B2 (cs)
BR (1) BR9811137A (cs)
CA (1) CA2297834C (cs)
CZ (1) CZ298680B6 (cs)
DE (1) DE69831576T2 (cs)
ES (1) ES2251097T3 (cs)
HU (1) HUP0003713A2 (cs)
IL (1) IL134163A0 (cs)
WO (1) WO1999007387A1 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
HUP0003713A2 (hu) 1997-08-08 2001-04-28 Nutrition 21 Króm és biotin tartalmú gyógyászati készítmény II típusú diabétesz kezelésére
US6376549B1 (en) 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
IL141967A0 (en) 1998-09-17 2002-03-10 Akesis Pharm Inc Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders
DE60214849T2 (de) * 2001-02-27 2007-04-26 Nutrition 21, Inc. Chromium/biotin behandlung von dyslipidämie
WO2003090671A2 (en) * 2002-04-23 2003-11-06 Nutrition 21, Inc. Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
ATE476188T1 (de) * 2002-05-14 2010-08-15 Nipro Corp Medikament zur prävention und behandlung von familiärer amyloid polyneuropathie
JP2004043443A (ja) * 2002-05-14 2004-02-12 Kumamoto Technology & Industry Foundation アミロイドーシスの予防及び治療のための医薬
JP2004203863A (ja) * 2002-12-09 2004-07-22 Taisho Pharmaceut Co Ltd 抗糖尿病用組成物
CN1320925C (zh) * 2005-03-30 2007-06-13 淮北市辉克药业有限公司 长期使用的治疗糖尿病的复方制剂
CA3021932C (en) * 2007-01-31 2020-12-15 Jds Therapeutics, Llc Use of chromium histidinate for treatment of cardiometabolic disorders
WO2008112706A1 (en) 2007-03-13 2008-09-18 Nutrition 21, Inc. Methods and compositions for the sustained release of chromium
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
CN105749253A (zh) 2011-03-01 2016-07-13 Jds治疗有限公司 用于预防和治疗糖尿病、低血糖症及相关病症的胰岛素和铬组合物
ES2395529B1 (es) 2011-06-08 2014-04-11 Pri, S.A. Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2.
CN102488220A (zh) * 2011-11-28 2012-06-13 中哈福生物医药科技（上海）有限公司 降血糖组合物，其制备方法及具有降血糖功能的保健食品
GB2564295A (en) 2016-02-11 2019-01-09 Nutrition 21 Llc Chromium containing compositions for improving health and fitness
US10820617B1 (en) 2018-03-29 2020-11-03 Government Of The United States, As Represented By The Secretary Of The Air Force All inclusive electrolytes, vitamins, and protein powder training supplement

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315927A (en) * 1980-08-08 1982-02-16 The United States Of America As Represented By The Secretary Of Agriculture Dietary supplementation with essential metal picolinates
US5087623A (en) * 1988-05-31 1992-02-11 Nitrition 21 Chromic picolinate treatment
US6140304A (en) 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
AU646840B2 (en) * 1990-02-05 1994-03-10 Board Of Regents, The University Of Texas System Dietary supplements comprising vitamins and minerals
US5336672A (en) * 1992-07-21 1994-08-09 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Increasing egg production in poultry
US5470846A (en) * 1994-01-14 1995-11-28 Sandyk; Reuven Treatment of neurological and mental disorders
US5496827A (en) * 1994-07-15 1996-03-05 Patrick; Jay Compositions for the transdermal delivery of nutrients
US5744161A (en) * 1995-02-24 1998-04-28 Sabinsa Corporation Use of piperine as a bioavailability enhancer
US6329361B1 (en) * 1995-05-12 2001-12-11 Nutrition 21 High-dose chromic picolinate treatment of type II diabetes
US5597585A (en) * 1995-12-26 1997-01-28 Williams; Andrew H. Vitamin/mineral composition
US5635535A (en) * 1996-04-05 1997-06-03 Wagstaff; Robert K. Method for increasing blood glucose levels
HUP0003713A2 (hu) 1997-08-08 2001-04-28 Nutrition 21 Króm és biotin tartalmú gyógyászati készítmény II típusú diabétesz kezelésére
US5789401A (en) * 1997-08-08 1998-08-04 Nutrition 21 High-dose chromium/biotin treatment of type II diabetes
US6048846A (en) * 1998-02-26 2000-04-11 Cochran; Timothy M. Compositions used in human treatment
US6365176B1 (en) 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy

Also Published As

Publication number Publication date
WO1999007387A1 (en) 1999-02-18
CA2297834C (en) 2008-09-30
EP1001793B1 (en) 2005-09-14
DE69831576T2 (de) 2006-06-14
CA2297834A1 (en) 1999-02-18
USRE39480E1 (en) 2007-01-23
BR9811137A (pt) 2000-07-18
AU751431B2 (en) 2002-08-15
CZ298680B6 (cs) 2007-12-19
ES2251097T3 (es) 2006-04-16
HUP0003713A2 (hu) 2001-04-28
DE69831576D1 (de) 2005-10-20
EP1001793A1 (en) 2000-05-24
ATE304364T1 (de) 2005-09-15
JP2001513506A (ja) 2001-09-04
AU8765198A (en) 1999-03-01
CN1273531A (zh) 2000-11-15
CZ2000324A3 (cs) 2001-03-14

Similar Documents

Publication Publication Date Title
EP1576956A3 (en) Chromium/biotin treatment of type II diabetes
IL134163A0 (en) Chromium/biotin treatment of type ii diabetes
AP2001002109A0 (en) Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin.
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
MY140557A (en) Pyrazolopyrimidines and pyrrolopyrimidines for treatment of neuronal and other disorders
MX9605023A (es) Compuestos substituidos de imidazolidin-2,4-diona como substancias farmaceuticamente activas.
BR9610838A (pt) Processo para tratar um indivìduo tendo uma condição patológica envolvendo neovascularização.
ZA200004016B (en) An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition.
AU7500794A (en) Novel use of dexmedetomidine
DE60214849D1 (de) Chromium/biotin behandlung von dyslipidemia
MX9602442A (es) Un tratamiento con fluoroquinolona a dosis unica elevada.
EP1007055A4 (en) METHODS OF ADMINISTERING AMIFOSTINE
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
BG102087A (en) The use of pyrrolidine derivatives for the treatment of alcoholism
AU6479000A (en) Novel use of prodigiosin for treating diabetes mellitus
AU4530796A (en) Treating disorders characterised by excessive cell proliferation with sclareolide
EP1007050A4 (en) METHOD FOR THE TREATMENT OF DRUG ADDICTION
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
CA2319686A1 (fr) Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet
AU5434899A (en) Cancer treatment
IL126157A0 (en) Method for treating excessive aggression
TW200517118A (en) Anti tumor agent
UA10249A (uk) Спосіб лікування діабетичних ангіопатій
UA10754A (uk) Спосіб лікуваhhя артеріальhих гіпертеhзій різhого геhезу
UA30659A (uk) Спосіб купіровання опіатної залежності

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed